The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico.

Moye-Holz, Daniela; van Dijk, Jitse P; Reijneveld, Sijmen A; Hogerzeil, Hans V

Moye-Holz, Daniela; van Dijk, Jitse P; Reijneveld, Sijmen A; Hogerzeil, Hans V.

Afiliación

Moye-Holz D; Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: danymoyeholz@gmail.com.
van Dijk JP; Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Reijneveld SA; Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Hogerzeil HV; Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Value Health Reg Issues ; 20: 129-135, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31374426

Asunto(s)

Antineoplásicos/economía; Costos de los Medicamentos; Negociación; Antineoplásicos/uso terapéutico; Países en Desarrollo/economía; Accesibilidad a los Servicios de Salud/economía; Humanos; México

Palabras clave

Mexico; access; cancer medicines; high prices; patented medicines; price negotiation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Negociación / Costos de los Medicamentos / Antineoplásicos Tipo de estudio: Health_economic_evaluation Límite: Humans País/Región como asunto: Mexico Idioma: En Revista: Value Health Reg Issues Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google